1. Home
  2. PPSI vs LEXX Comparison

PPSI vs LEXX Comparison

Compare PPSI & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Power Solutions Inc.

PPSI

Pioneer Power Solutions Inc.

HOLD

Current Price

$3.14

Market Cap

36.3M

Sector

Industrials

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.72

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPSI
LEXX
Founded
2008
2004
Country
United States
Canada
Employees
N/A
7
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
16.2M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
PPSI
LEXX
Price
$3.14
$0.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$1.50
AVG Volume (30 Days)
70.4K
133.9K
Earning Date
04-14-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
1626.32
N/A
EPS
N/A
N/A
Revenue
$22,879,000.00
N/A
Revenue This Year
$26.84
N/A
Revenue Next Year
$10.26
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.26
$0.46
52 Week High
$5.70
$1.90

Technical Indicators

Market Signals
Indicator
PPSI
LEXX
Relative Strength Index (RSI) 33.12 49.84
Support Level $2.85 $0.62
Resistance Level $4.05 $0.87
Average True Range (ATR) 0.23 0.08
MACD -0.00 0.00
Stochastic Oscillator 7.14 32.68

Price Performance

Historical Comparison
PPSI
LEXX

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: